Turkmenistan Medical Device Competent Authorities: A Three-Tier Structure

1. Key takeaways

Device review in Turkmenistan is a three-tier structure:

• Policy tier: the Ministry of Health and Medical Industry of Turkmenistan (Turkmen: Türkmenistanyň Saglygy goraýyş we derman senagaty ministrligi), official website https://www.saglykhm.gov.tm/;
• Executive tier: the State Center for Registration of Medicinal Products and State Quality Control, subordinate to the ministry, which is the authorized body that actually receives applications, organizes review and issues certificates;
• Technical review tier: the Pharmacopoeia Committee, which issues opinions on the impact of variation documents on safety, quality and efficacy, and adopts protocols of approval or rejection.

The third tier is the most easily overlooked: the Pharmacopoeia Committee is an institution from the drug regime, yet it plays a decisive role in variation review for devices.

2. Legal basis

3. Expert insights

Insight 1: the name of the ministry is itself an important piece of information.

In the full Turkmen name Türkmenistanyň Saglygy goraýyş we derman senagaty ministrligi, the phrase derman senagaty means pharmaceutical industry. In other words, health and the pharmaceutical industry sit within a single ministry. This explains why device registration has long remained attached to the drug regime — the organizational logic of the competent authority itself combines health with the pharmaceutical industry.

Insight 2: the name of the executive body varies slightly across sources, but the functions are identical.

During this verification round, the executive body appeared as the State Center for Registration of Medicinal Products and State Quality Control and as the Center for Registration and State Quality Control of Medicinal Products. The functional descriptions are fully consistent: receiving registration applications, organizing expert review, arranging laboratory analysis, entering products into the national registration register, and issuing registration certificates. We use the State Center for Registration of Medicinal Products and State Quality Control uniformly, shortened to the State Registration Center.

Insight 3: the involvement of the Pharmacopoeia Committee in device variations is the most direct evidence that devices are attached to the drug regime.

The Pharmacopoeia Committee is the technical body responsible for the pharmacopoeia and drug standards. In device variation review its role is to conduct expert evaluation of the variation documents, issue an opinion on the impact of the variation on safety, quality and efficacy, and adopt a protocol approving or rejecting it on that basis. When preparing variation dossiers, the argumentation should be organized around the three pillars of safety, quality and efficacy, rather than in the risk-management language customary in the device industry.

Insight 4: site inspections are usually not performed, but discretion is reserved.

Multiple sources consistently state that on-site inspection of the manufacturer is usually not a required step, but whether an inspection takes place is at the discretion of the competent authority. The practical reading is: do not treat usually no inspection as meaning there will never be an inspection — quality system documentation (ISO 13485, evidence of production conditions) must still be complete, because the discretion can be exercised at any time.

Insight 5: an A-grade observation on the ministry website — digitalization is higher than expected.

Direct access to saglykhm.gov.tm shows a digital services section (Sanly hyzmatlar) offering online services such as the list of medicines and products for healthcare purposes, with links to the national e-services portal e.gov.tm and the digital portal sanly.tm. This differs from the common stereotype of a closed e-government environment in Turkmenistan; Article 47 of this series examines this in detail.

4. Practical recommendations

1. Use the full ministry name plus the official domain in external documents; do not substitute abbreviations for the first mention of an institution.
2. Write variation dossiers in the three-pillar structure of safety, quality and efficacy, aligned with the review logic of the Pharmacopoeia Committee.
3. Prepare quality system documentation on the assumption that an inspection may occur, and do not scale it down because inspections are usually not performed.
4. Establish fixed communication points with the local representative, who confirms the document list and progress with the State Registration Center.
5. Add saglykhm.gov.tm and e.gov.tm to the routine monitoring list to track updates of the digital services.

5. Verification checklist

• □ The competent authority is confirmed as the Ministry of Health and Medical Industry of Turkmenistan (saglykhm.gov.tm).
• □ The executive body is confirmed as the State Center for Registration of Medicinal Products and State Quality Control.
• □ Variation dossiers are organized in the safety / quality / efficacy three-pillar structure.
• □ Quality system documentation is complete to the standard of a possible on-site inspection.
• □ Fixed communication points with the local representative are established.
• □ saglykhm.gov.tm and e.gov.tm are included in the official information monitoring list.

Regulatory information verified as of October 30, 2026. The content cited in this document was checked against Law No. 319-V on Drug Provision (January 12, 2016), the Regulation on the State Registration of Medicines and Medical Devices approved by the Ministry of Health, and the ministry website (https://www.saglykhm.gov.tm/, including the digital services section and the official links to e.gov.tm and sanly.tm), which was verified by direct access.

GRZAN support in Turkmenistan: GRZAN provides registration support to manufacturers, importers and authorized representatives for this market. Local resources can be coordinated, including licensed importing entities and authorized representative arrangements, covering national registration submission, the consular legalization chain for documents, delivery of samples, alignment with mandatory TDS certification, and customs clearance support. Service capabilities include classification judgment, selection of the registration pathway, preparation of dossiers in the national format, notarization and consular legalization, preparation of testing and stability documentation, organization of GMP and ISO 13485 evidence, variations and renewal, and vigilance and post-market maintenance. Contact: info@grzanglobal.com.